Table 1.
Demographic and clinical data of the sample and by gender
| Age, mean (SD), years | Total sample (n = 1,142) 61 (17) | Male (n = 601) 61.5 (16) | Female (n = 541) 60 (17.5) |
|---|---|---|---|
| Gender, male/female, n (%) | 601 (52.5)/541 (47.5) | − | − |
| Weight, mean (SD), kg* | 70 (15) | 75 (13) | 64 (14) |
| Height, mean (SD), cm* | 166 (10) | 171 (8.5) | 159 (7) |
| BMI, mean (SD), kg/cm2 | 25.4 (3.0) | 25.6 (4.2) | 25.3 (2.8) |
| Smoking status, n (%)* | |||
| Active | 96 (8.5) | 65 (10.8) | 31 (5.7) |
| None or former | 1,046 (91.5) | 536 (89.2) | 509 (94.3) |
| Medical comorbidities, n (%) | |||
| Hypertension* | 291 (25.5) | 176 (29.3) | 115 (21.3) |
| Diabetes | 145 (13) | 90 (15) | 55 (10.2) |
| Cardiovascular disease | 144 (13) | 90 (15) | 54 (10) |
| Rheumatological disease | 61 (5.5) | 37 (6.2) | 24 (4.4) |
| Asma | 55 (5) | 30 (5) | 25 (4.6) |
| Obesity | 54 (5) | 34 (5.6) | 20 (3.7) |
| COPD | 51 (4.5) | 31 (5.2) | 20 (3.7) |
| Stroke | 29 (2.5) | 17 (2.8) | 12 (2.3) |
| Other (cancer, kidney disease) | 105 (9) | 52 (8.6) | 53 (9.8) |
| Days at hospital, mean (SD)* | 14 (12) | 14.6 (12.5) | 12.5 (11) |
| ICU admission | |||
| Yes/no, n (%)* | 80 (7)/1,062 (93) | 51 (8.4)/450 (91.6) | 29 (5.4)/512 (94.6) |
| Stay at ICU, mean (SD), days | 15 (13) | 15 (12.5) | 14.5 (15) |
| Cardio-respiratory post-COVID-19 symptoms, n (%) | |||
| Fatigue* | 695 (61) | 329 (54.7) | 367 (67.8) |
| Dyspnoea with activity* | 627 (55) | 289 (48.1) | 338 (62.5) |
| Dyspnoea at rest* | 268 (23.5) | 114 (19) | 154 (28.4) |
| Chest pain | 80 (7) | 42 (7) | 38 (7) |
| Tachycardia-palpitations | 77 (6.5) | 43 (7.1) | 34 (6.3) |
| Cough | 24 (2) | 12 (2) | 12 (2) |
BMI, body mass index; COPD, chronic obstructive pulmonary disease; SD, standard deviation; ICU, intensive care unit.
*
Significant differences between males and females.